Key result
Review outlines evaluation, staging, and prognostic impact of congestive hepatopathy in advanced heart failure.
Synthesizes current diagnostic approaches for liver dysfunction in advanced HF; leaves open the need for.
Heart failure (HF) is one of the most prevalent conditions, estimated to affect more than 64 million individuals worldwide 1. The HF prevalence has increased over the last decades due to novel therapeutic options and an aging population. It is projected that in the United States (US), the prevalence of HF will increase by approximately 46% from 2012 to 2030 1. Advanced heart failure (AHF) involves patients who have failed conventional treatment strategies. Management options include palliation or candidacy for left ventricular assist device (LVAD) or heart transplant (HTx)2.
No takes yet. Share an insight, caveat, or question.
Mani et al. (2026) conducted a review in Congestive Hepatopathy in Advanced Heart Failure. This paper reviews the evaluation, staging, and prognosis of congestive hepatopathy in advanced heart failure, but the abstract reports no specific quantitative study results.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: